Publications
106 publications
Funding
10 grantsView NIH portfolio on RePORTER ↗
Active
5 grants- MPIP50CA217694-08Project 1: Molecular Determinants of GIST PathogenesisNCI · 2018–2029 · via NIH RePORTER
- PIT32CA009512-37Clinical Scholars Biomedical Research Training ProgramNCI · 1985–2028 · via NIH RePORTER
- PIR01CA280657-04Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancerNCI · 2023–2028 · via NIH RePORTER
- PIR01FD007544-03Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)NIH · 2022–2027 · via NIH RePORTER
- PIU01CA252048-05Understanding and targeting MAPK pathway activation in NF1-deficient malignant peripheral nerve sheath tumor (MPNST)NCI · 2021–2026 · via NIH RePORTER
Completed grants (5)
- MPIR01CA228216-05Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancerNCI · 2018–2024 · via NIH RePORTER
- PIR01FD005731-04Phase2 trial of MEK162 & imatinib combined therapy in GIST, IND119794(09/20/2013)NIH · 2017–2021 · via NIH RePORTER
- PIDP2CA174499-01An integrative approach to target lineage-specific oncogenic transcription factorNCI · 2012–2017 · via NIH RePORTER
- PIK08CA151660-05Elucidating the roles of ETV1 in the pathogenesis of GISTNCI · 2011–2016 · via NIH RePORTER
- PIF32CA130372-02Elucidating Mechanisms of Histone H2B Dynamic Modification in Mammalian ApoptosisNCI · 2007–2009 · via NIH RePORTER